S100B and myeloid sarcoma: In this respect, we showed that in the relapsing–remitting experimental autoimmune encephalomyelitis (EAE) mouse MS model, the inhibitor of S100B activity, pentamidine (PTM), ameliorates clinical scores and neuropathologic-biomolecular parameters [29]; the finding was later confirmed also in the chronic EAE mouse model [32].